Business Wire

BITMEX

1.12.2021 06:07:10 CET | Business Wire | Press release

Share
BitMEX Introduces Most Rewarding Crypto ‘Earn’ Product Yet

Global cryptocurrency trading platform BitMEX announced the launch of BitMEX EARN . This interest-bearing product offers the highest annual percentage rate (APR) of all public Earn products.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005722/en/

The product rewards users who subscribe their funds for a set period with an interest payout, ranging from 14 - 100% APR. Furthermore, BitMEX EARN is the only product of its type in the market that is 100% insurance fund backed. All payouts are guaranteed by the BitMEX insurance fund - one of the largest funds in the industry.

The first cryptocurrency available on BitMEX EARN is Tether (USDT ERC-20). BitMEX customers who subscribe to the product before 7 December 2021 can subscribe to an early bird offer to earn up to a 100% APR on Tether for deposits up to USDT 1,000 per user and up to 14% APR for deposits up to USDT 100,000 per user. More details on BitMEX EARN can be found here .

Alexander Höptner, Chief Executive Officer at BitMEX, said: “BitMEX EARN allows anyone to easily generate a double-digit return - much higher than the rates you'll get with TradFi products. Our EARN products' APR far outpaces what's offered on other crypto platforms, whose headline rates on similar products are usually tied to unattainable staking requirements. We've also streamlined our subscription process, making this a product that appeals to all kinds of traders - not just the pros.”

BitMEX EARN is part of its ambitious business transformation, known as its 'Beyond Derivatives' strategy. BitMEX is adding five new global business segments (Spot, Brokerage, Custody, Information Products, and Academy) after having launched a rigorous user verification and compliance programme in 2020. In January 2021, BitMEX announced the completion of its user verification programme , which made BitMEX one of the largest crypto derivatives exchanges to have a fully verified active user base. BitMEX EARN follows the company’s introduction of USDT for margin and settlement on perpetual swaps in November 2021.

BitMEX EARN launches on 1 December 2021, with subscriptions open for the first two products until 7 December 2021 (or until fully subscribed). To subscribe or learn more, visit the BitMEX EARN webpage .

About BitMEX

BitMEX is a trading platform that offers investors access to the global digital currency financial markets. BitMEX is owned by HDR Global Trading Limited. To learn more about BitMEX, our vision, growing team, and the road ahead, please follow us on Twitter , Telegram , and the BitMEX Blog . For further inquiries, please contact press@bitmex.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The Bolivarian Republic of Venezuela Announces the Initiation of a Comprehensive Public Debt Restructuring Process13.5.2026 22:08:00 CEST | Press release

The Bolivarian Republic of Venezuela announces today its decision to initiate a comprehensive restructuring of its external public debt obligations. CONTEXT & RATIONALE Over the past decade, Venezuela's economy has been severely impacted by external shocks – from the end of the commodity super-cycle to foreign sanctions and COVID-19 – resulting in a sharp economic contraction, a protracted default since 2017, and a ballooning of public sector liabilities. The country nonetheless possesses a strong economic potential, including unique hydrocarbon and mineral endowments. A recovery is underway, and Venezuela is committed to accelerating it through a comprehensive reform agenda in support of growth, fiscal sustainability, monetary stabilization, and enhanced governance. Restoring public debt sustainability is central to this agenda: the current debt overhang constrains external financing, limits public investment capacity, and prevents full re-engagement with the international financial s

Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise13.5.2026 21:00:00 CEST | Press release

Proposed acquisition extends Boomi’s AI gateway capabilities, enabling enterprises to govern massive volumes of traffic for production-ready AI Boomi, the data activation company for AI, today announced it has signed a letter of intent to acquire Lunar.dev, an innovator in AI and MCP gateway. The proposed acquisition is expected to enrich the Boomi Enterprise Platform and Boomi Connect with advanced capabilities to govern and scale AI usage across enterprise systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513850557/en/ Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise As organizations move from AI experimentation to production, controlling how agents and AI applications interact with LLMs at scale has become critical. Lunar.dev addresses this need with an AI gateway that delivers granular, policy-driven control over AI interactions, with the visibility, securi

BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma13.5.2026 19:27:00 CEST | Press release

BEQALZI is a foundational BCL2 inhibitor designed for greater potency and selectivity, with potential to improve efficacy, tolerability, and convenience versus others in the classApproval of BEQALZI marks the first new BCL2 inhibitor approved in a decade in the U.S. and the only BCL2 inhibitor approved in MCL, aiming to set a new standard of innovation BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BEQALZI™(bee-KAHL-zee; sonrotoclax), a foundational, next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase (BTK) inhibitor. BEQALZI was designed to enhance BCL2 inhibition—with greater potency, selectivity, and a pharmacologic profile with potential to improve efficacy, tolerability, a

Boomi Unveils Innovations That Power the Agentic Enterprise13.5.2026 16:30:00 CEST | Press release

Orchestration capabilities simplify workflows, while advanced agent connectivity and an enhanced context layer activate data and scale AI Boomi, the data activation company for AI, today announced a major expansion of the Boomi Enterprise Platform at Boomi World 2026, introducing new capabilities across orchestrated agentic workflows, agentic engineering, governed agent connectivity, grounded agent context, and localized agent infrastructure. Together, these innovations are designed to power the agentic enterprise — where agents and humans work together to drive action and operationalize AI at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513996223/en/ Boomi Unveils Innovations That Power the Agentic Enterprise The enterprise has reached a defining moment as AI becomes the primary interface for work and MCP emerges as the new standard. While the shift toward a headless, agentic enterprise is inevitable, this visio

Boomi and Red Hat Collaborate on Production-Ready Agentic AI13.5.2026 16:30:00 CEST | Press release

Companies team to deliver a unified, enterprise-scale agentic stack to help organizations with managing data sovereignty and optimizing AI costs Boomi, the data activation company for AI, and Red Hat, the world’s leading provider of open source solutions, today announced a strategic collaboration to deliver a single, integrated stack for deploying agentic AI at scale. For many organizations, building production AI today means assembling numerous disconnected vendor choices spanning agent builders, orchestration tools, governance platforms, model providers, integration middleware, and security infrastructure, which can lead to data leaks and unpredictable costs. Boomi and Red Hat are working together to simplify AI innovation for customers by bringing together Boomi’s Agentstudio with the enterprise-grade power of Red Hat AI. This makes it easier for organizations to build agents that solve real business problems while supporting corporate standards for sovereignty, infrastructure flexi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye